These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6873021)
1. Approach to risk assessment for genotoxic carcinogens based on data from the mouse skin initiation-promotion model. Burns F; Albert R; Altshuler B; Morris E Environ Health Perspect; 1983 Apr; 50():309-20. PubMed ID: 6873021 [TBL] [Abstract][Full Text] [Related]
2. Overview of tumor promotion in animals. Slaga TJ Environ Health Perspect; 1983 Apr; 50():3-14. PubMed ID: 6347683 [TBL] [Abstract][Full Text] [Related]
3. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols. Iversen OH APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481 [TBL] [Abstract][Full Text] [Related]
4. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene. Scribner JD; Scribner NK; McKnight B; Mottet NK Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231 [TBL] [Abstract][Full Text] [Related]
5. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type. Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681 [TBL] [Abstract][Full Text] [Related]
6. Relationship of benign papillomas to cancer induction in mouse skin. Burns FJ; Albert RE Cancer Detect Prev; 1981; 4(1-4):99-107. PubMed ID: 6299565 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone. Verma AK; Garcia CT; Ashendel CL; Boutwell RK Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052 [TBL] [Abstract][Full Text] [Related]
8. Transmaternal modification of the Berenblum/Mottram experiment in mice. Schweizer J; Loehrke H; Goerttler K Bull Cancer; 1978; 65(3):265-70. PubMed ID: 102383 [TBL] [Abstract][Full Text] [Related]
9. Association of carcinoma yield with early papilloma development in SENCAR mice. Bull RJ; Robinson M; Laurie RD Environ Health Perspect; 1986 Sep; 68():11-7. PubMed ID: 3780623 [TBL] [Abstract][Full Text] [Related]
11. Is the initiation-promotion regimen in mouse skin relevant to complete carcinogenesis? Scribner JD; Scribner NK Carcinog Compr Surv; 1982; 7():13-8. PubMed ID: 6802488 [No Abstract] [Full Text] [Related]
12. Effect of promoters on incidence of bladder cancer in experimental animal models. Hicks RM Environ Health Perspect; 1983 Apr; 50():37-49. PubMed ID: 6873029 [TBL] [Abstract][Full Text] [Related]
13. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide. Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134 [TBL] [Abstract][Full Text] [Related]
14. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Hennings H; Devor D; Wenk ML; Slaga TJ; Former B; Colburn NH; Bowden GT; Elgjo K; Yuspa SH Cancer Res; 1981 Mar; 41(3):773-9. PubMed ID: 6780187 [TBL] [Abstract][Full Text] [Related]
15. Transplacental skin tumor initiation of Ha/ICR mice at different fetal ages. Morris EP; Burns FJ; Albert RE Cancer Res; 1983 Sep; 43(9):4271-4. PubMed ID: 6409402 [TBL] [Abstract][Full Text] [Related]
16. Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin. Slaga TJ; Gleason GL; DiGiovanni J; Sukumaran KB; Harvey RG Cancer Res; 1979 Jun; 39(6 Pt 1):1934-6. PubMed ID: 109189 [TBL] [Abstract][Full Text] [Related]
17. Tumor promotion by a hydroperoxide metabolite of butylated hydroxytoluene, 2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone, in mouse skin. Taffe BG; Kensler TW Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):291-303. PubMed ID: 3141995 [TBL] [Abstract][Full Text] [Related]
18. Initiation, promotion and complete carcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine or ethylnitrosourea in the Sencar mouse skin tumorigenesis model. O'Connell JF; Nesnow S; Slaga TJ Cancer Lett; 1987 Nov; 37(3):301-10. PubMed ID: 3677061 [TBL] [Abstract][Full Text] [Related]
19. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919 [TBL] [Abstract][Full Text] [Related]
20. Sensitivity of subpopulations of mouse skin papillomas to malignant conversion by urethane or 4-nitroquinoline N-oxide. Hennings H; Shores R; Balaschak M; Yuspa SH Cancer Res; 1990 Feb; 50(3):653-7. PubMed ID: 2105160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]